Influence of in line monitored fluid bed granulation process parameters on the stability of Ethinylestradiol
Katrin Roßteuscher-Carl1, Sabine Fricke2, Michael C Hacker3
1Jenapharm GmbH & Co. KG, Otto-Schott-Str. 15, 07745 Jena, Germany; University of Leipzig, Pharmaceutical Technology, Institute of Pharmacy, Eilenburger Str. 15A, 04317 Leipzig, Germany.
Abstract:
Ethinylestradiol (EE) as a highly active and low dosed compound is prone to oxidative degradation. The stability of the drug substance is therefore a critical parameter that has to be considered during drug formulation. Beside the stability of the drug substance, granule particle size and moisture are critical quality attributes (CQA) of the fluid bed granulation process which influence the tableting ability of the resulting granules. Both CQA should therefore be monitored during the production process by process analytic technology (PAT) according to ICH Q8. This work focusses on the effects of drying conditions on the stability of EE in a fluid-bed granulation process. We quantified EE degradation products 6-alpha-hydroxy-EE, 6-beta-hydroxy-EE, 9(11)-dehydro-EE and 6-oxo-EE during long time storage and accelerated conditions. PAT-tools that monitor granule particle size (Spatial filtering technology) and granule moisture (Microwave resonance technology) were applied and compared with off-line methods. We found a relevant influence of residual granule moisture and thermic stress applied during granulation on the storage stability of EE, whereas no degradation was found immediately after processing. Hence we conclude that drying parameters have a relevant influence on long term EE stability.
Related Concept Videos
Factors Influencing Drug Absorption: Pharmaceutical Parameters
Drug Product Stability
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules


